NS
CRDF icon

NBC Securities’s Cardiff Oncology CRDF Stock Holding History

NBC Securities’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$2.81K – 2615
2025
Q4 		$2.81K Hold
1,000
– – ﹤0.01% 2354
2025
Q3 		$2.06K Hold
1,000
– – ﹤0.01% 2411
2025
Q2 		$3K Hold
1,000
– – ﹤0.01% 2211
2025
Q1 		$3K Buy
+1,000
New +$3.96K ﹤0.01% 1955

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

NBC Securities's CRDF Position: Q1 2026 in Review

NBC Securities sold out of Cardiff Oncology (CRDF) in Q1 2026, closing a stake of 1,000 shares — an estimated $2.81K sold.

NBC Securities first reported a position in CRDF in Q1 2025 and held it in 4 quarters. The position peaked at $3K in Q2 2025. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • NBC Securities reported no remaining Cardiff Oncology position as of Q1 2026 after selling out during the quarter.
  • NBC Securities sold 1,000 Cardiff Oncology shares in Q1 2026, an estimated $2.81K.
  • NBC Securities first reported a position in Cardiff Oncology in Q1 2025 and held it in 4 quarters.
  • NBC Securities's Cardiff Oncology position peaked at $3K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on NBC Securities's 13F filing for Q1 2026, filed 14 Apr 2026.